Nj Gets Bristol-myers Squibb Money Over Abilify

Asbury Park - Home, Asbury Park Press
Thu, 12/08/2016 - 1:53pm

Bristol-Myers Squibb will pay a total of $19.5 million to 43 states, including New Jersey, to settle charges that it made misleading claims about Abilify.        

NEXT
Topics:  New Jersey   Monmouth County   Neptune   
RELATED ARTICLES
BING NEWS:
  • Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
    Analysts have recently evaluated Bristol-Myers Squibb and provided 12-month price targets. The average target is $50.0, accompanied by a high estimate of $54.00 and a low estimate of $43.00. This ...
    04/26/2024 - 6:13 am | View Link
  • Bristol Myers Squibb to close 256K sf campus in Redwood City
    Bristol Myers Squibb will close a 256,000-square-foot campus in Redwood City and squish operations into its Brisbane offices to cut costs. The New Jersey-based drugmaker will vacate the three ...
    04/26/2024 - 4:38 am | View Link
  • Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
    One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in the Bay Area concentrated on the tumor microenvironment.  | Bristol Myers ...
    04/26/2024 - 3:59 am | View Link
  • Is Bristol Myers Squibb Stock a Millionaire Maker?
    Bristol Myers Squibb faces some challenges, but there could be light at the end of the tunnel for long-term investors.
    04/25/2024 - 3:45 am | View Link
  • Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
    Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.
    04/25/2024 - 12:35 am | View Link
  • More

 

NEXT